1 | * D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg | - | - | - | - | 1件: 41 41 💬 |
2 | * D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg | - | - | - | - | 1件: 41 41 💬 |
3 | 0,5 mg seasonal influenza vaccine i.m. | - | - | - | - | 1件: 51 51 💬 |
4 | 10% Metronidazole Ointment (Vandazole (TN)) | 1件: Metronidazole Metronidazole (Metronidazole Vaginal) | 1件: Metronidazole
Metronidazole
(Vandazole (TN)) 💬 | - | - | 1件: 96 96 💬 |
5 | 13 valent conjugated pneumococcal vaccine | - | - | - | - | 1件: 265 265 💬 |
6 | 13-valent pneumococcal conjugate vaccine | - | - | - | - | 2件: 46 46, 53 💬 |
7 | 13-valent pneumococcal conjugate vaccine (13-PCV) | - | - | - | - | 1件: 13 13 💬 |
8 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | 1件: 96 96 💬 |
9 | 2011-2012 seasonal flu vaccine Intramuscular | - | - | - | - | 2件: 3 3, 113 💬 |
10 | 2011-2012 seasonal flu vaccine Subcutaneous | - | - | - | - | 2件: 3 3, 113 💬 |
11 | 23-valent pneumococcal polysaccharide vaccine | - | - | - | - | 3件: 13 13, 46, 53 💬 |
12 | 23-valent pneumococcal polysaccharide vaccine (23-PPV) | - | - | - | - | 1件: 13 13 💬 |
13 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | 1件: 96 96 💬 |
14 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | 2件: 96 96, 97 💬 |
15 | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream (Vagifem (TN)) | 2件: Estradiol Estradiol (Estradiol Vaginal Inserts), Lidocaine (Vasocaine) | 3件: Estradiol
Estradiol
(Vagifem (TN)),
Lidocaine
,
Lidocaine hydrochloride monohydrate
💬 | 7件: ESR1 ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬 | 1件: 226 226 💬 |
16 | 7-valent Pneumococcal Conjugate vaccine | - | - | - | - | 1件: 46 46 💬 |
17 | Abatacept + Vaccines | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬 | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
18 | Adipose-derived stromal vascular fraction cells | - | - | - | - | 1件: 6 6 💬 |
19 | Agomelatine (Valdoxan (TN)) | 1件: Agomelatine Agomelatine (Valdoxan) | 1件: Agomelatine
Agomelatine
(Valdoxan (TN)) 💬 | 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬 |
20 | Agomelatine or PIacebo (Valdoxan (TN)) | 1件: Agomelatine Agomelatine (Valdoxan) | 1件: Agomelatine
Agomelatine
(Valdoxan (TN)) 💬 | 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬 |
21 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件: 46 46 💬 |
22 | Amoxicillin, metronidazole and doxycycline (Vandazole (TN)) | 3件: Amoxicillin Amoxicillin, Doxycycline, Metronidazole (Metronidazole Vaginal) | 5件: Amoxicillin
Amoxicillin
,
Doxycycline
,
Metronidazole
(Vandazole (TN)),
Amoxicillin
,
Doxycycline
💬 | - | - | 1件: 97 97 💬 |
23 | Amyl Nitrite (Vaporole (TN)) | 2件: Amyl Nitrite Amyl Nitrite, Nitrite | 1件: Amyl nitrite
Amyl nitrite
(Vaporole (TN)) 💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬 |
24 | Amyl nitrite inhalation (Vaporole (TN)) | 2件: Amyl Nitrite Amyl Nitrite, Nitrite | 1件: Amyl nitrite
Amyl nitrite
(Vaporole (TN)) 💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬 |
25 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | 6件: 46 46, 49, 50, 51, 53, 107 💬 |
26 | Autologous ADIpose derived stromal vascular fraction | - | - | - | - | 1件: 96 96 💬 |
27 | Autologous Stromal Vascular Fraction (SVF) | - | - | - | - | 1件: 85 85 💬 |
28 | Autologous stromal vascular fraction cells | - | - | - | - | 1件: 46 46 💬 |
29 | Autologous Tissue-Engineered Vascular Graft | - | - | - | - | 1件: 210 210 💬 |
30 | Azithromycin + Metronidazole (Vandazole (TN)) | 2件: Azithromycin Azithromycin, Metronidazole (Metronidazole Vaginal) | 3件: Metronidazole
Metronidazole
(Vandazole (TN)),
Azithromycin
,
Azithromycin
💬 | - | - | 1件: 96 96 💬 |
31 | Bacille Calmette-Guerin vaccine | - | - | - | - | 1件: 13 13 💬 |
32 | BCG TICE Vaccine | - | - | - | - | 1件: 299 299 💬 |
33 | Beclomethasone dipropionate (Vanceril (TN)) | 1件: Beclomethasone dipropionate Beclomethasone dipropionate (Vanceril Aem 50mcg) | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
(Vanceril (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 98 💬 |
34 | Belimumab plus Early Vaccination | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
35 | Belimumab plus Late Vaccination | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬 |
36 | Benazepril, Valsartan and Fluvastatin | 3件: Benazepril Benazepril, Fluvastatin, Valsartan | 3件: Valsartan
Valsartan
,
Benazepril
,
Fluvastatin
💬 | 3件: ACE ACE, AGTR1, HMGCR 💬 | 22件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 218 218 💬 |
37 | Biological/Vaccine: Allogeneic HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 1件: 6 6 💬 |
38 | Broncho-Vaxom | 1件: OM85 OM85 (Broncho-Vaxom) | - | - | - | 1件: 85 85 💬 |
39 | Cannabidiol vaginal suppository | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 226 226 💬 |
40 | Capsaicin vapor | 1件: Capsaicin Capsaicin (8-Methyl-N-vanillyl-6-nonenamide) | 1件: Capsaicin
Capsaicin
💬 | 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
41 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO (Vanceril (TN)) | 1件: Beclomethasone dipropionate Beclomethasone dipropionate (Vanceril Aem 50mcg) | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
(Vanceril (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
42 | Combination Product: Beclomethasone dipropionate in addition to refined oil (Vanceril (TN)) | 1件: Beclomethasone dipropionate Beclomethasone dipropionate (Vanceril Aem 50mcg) | 1件: Beclomethasone dipropionate
Beclomethasone dipropionate
(Vanceril (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
43 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | 1件: 65 65 💬 |
44 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | 3件: 13 13, 46, 51 💬 |
45 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | 4件: 13 13, 46, 51, 299 💬 |
46 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | 4件: 13 13, 46, 51, 299 💬 |
47 | COVID-19 vaccination | - | - | - | - | 1件: 13 13 💬 |
48 | COVID-19 vaccine | - | - | - | - | 3件: 46 46, 49, 51 💬 |
49 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | 1件: 299 299 💬 |
50 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | 3件: 46 46, 51, 299 💬 |
51 | COVID-19 Vaccine AstraZeneca | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 53 💬 |
52 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 💬 |
53 | COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 53 53 💬 |
54 | Covid-19 Vaccine Janssen | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 2件: 53 53, 299 💬 |
55 | COVID-19 Vaccine Janssen suspension for injection | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 1件: 299 299 💬 |
56 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | 2件: 53 53, 299 💬 |
57 | COVID-19 Vaccine Moderna | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 4件: 46 46, 51, 65, 299 💬 |
58 | COVID-19 Vaccine Moderna dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 1件: 299 299 💬 |
59 | COVID19 vaccine | - | - | - | - | 1件: 13 13 💬 |
60 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | 1件: 97 97 💬 |
61 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | 1件: 97 97 💬 |
62 | Diazepam (Valium (TN)) | 1件: Diazepam Diazepam (Valium 10 Tab) | 1件: Diazepam
Diazepam
(Valium (TN)) 💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 46 46, 155, 298 💬 |
63 | Diazepam, melatonin (Valium (TN)) | 2件: Diazepam Diazepam (Valium 10 Tab), Melatonin | 2件: Diazepam
Diazepam
(Valium (TN)),
Melatonin
💬 | 18件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, MTNR1A, MTNR1B 💬 | 8件: Circadian entrainment Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 💬 |
64 | ENALAPRIL VALSARTAN METHYLPREDNISONE | 3件: Enalapril Enalapril (Vasotec), Methylprednisone, Valsartan | 2件: Valsartan
Valsartan
,
Enalapril
💬 | 2件: ACE ACE, AGTR1 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬 |
65 | Epaxal Berna (virosomal hepatitis A vaccine) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 2件: 96 96, 97 💬 |
66 | Estradiol (Vagifem (TN)) | 1件: Estradiol Estradiol (Estradiol Vaginal Inserts) | 1件: Estradiol
Estradiol
(Vagifem (TN)) 💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 💬 |
67 | Estradiol 2 mg (Vagifem (TN)) | 1件: Estradiol Estradiol (Estradiol Vaginal Inserts) | 1件: Estradiol
Estradiol
(Vagifem (TN)) 💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 💬 |
68 | ESTRADIOL HEMIHYDRATE (Vagifem (TN)) | 1件: Estradiol Estradiol (Estradiol Vaginal Inserts) | 1件: Estradiol
Estradiol
(Vagifem (TN)) 💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬 |
69 | Estradiol valerate | 2件: Estradiol Estradiol (Estradiol Vaginal Inserts), Estradiol valerate | 2件: Estradiol
Estradiol
(Vagifem (TN)),
Estradiol valerate
💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 65 65 💬 |
70 | Ethinyl estradiol (Vagifem (TN)) | 2件: Estradiol Estradiol (Estradiol Vaginal Inserts), Ethinylestradiol | 2件: Estradiol
Estradiol
(Vagifem (TN)),
Ethinyl estradiol
💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 3件: 46 46, 49, 299 💬 |
71 | Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed). | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 💬 |
72 | Focetria (Monovalent MF59-Adjuvanted vaccine) | - | - | - | - | 3件: 46 46, 49, 271 💬 |
73 | GM-CSF, fosfomycin and metronidazole (Vandazole (TN)) | 2件: Fosfomycin Fosfomycin, Metronidazole (Metronidazole Vaginal) | 2件: Metronidazole
Metronidazole
(Vandazole (TN)),
Fosfomycin
💬 | - | - | 1件: 97 97 💬 |
74 | Group C meningococcal conjugate vaccine | - | - | - | - | 1件: 14 14 💬 |
75 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 2件: 13 13, 14 💬 |
76 | Haemophilus type b vaccine (conjugated) | - | - | - | - | 1件: 14 14 💬 |
77 | HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 💬 |
78 | Hepatitis A Vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 💬 |
79 | Hepatitis A vaccine ( HAVRIX or EPAXAL) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 💬 |
80 | Hepatitis A vaccine and tetanus vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 💬 |
81 | Hepatitis B Vaccine | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 💬 |
82 | HEPATITIS B VACCINE (RDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 💬 |
83 | Herpes Zoster Subunit (HZ/su) Vaccine | - | - | - | - | 1件: 49 49 💬 |
84 | Herpes Zoster Vaccine | - | - | - | - | 3件: 46 46, 96, 271 💬 |
85 | Histrelin (Vantas (TN)) | 1件: Histrelin Histrelin (Vantas) | 1件: Histrelin
Histrelin
(Vantas (TN)) 💬 | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 💬 |
86 | Histrelin Subcutaneous Implant (Vantas (TN)) | 1件: Histrelin Histrelin (Vantas) | 1件: Histrelin
Histrelin
(Vantas (TN)) 💬 | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 💬 |
87 | HPV prophylactic vaccine Gardasil | 4件: Human papillomavirus type 11 L1 capsid protein antigen Human papillomavirus type 11 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 💬 |
88 | Human papillomavirus vaccination (Gardasil) | 4件: Human papillomavirus type 11 L1 capsid protein antigen Human papillomavirus type 11 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 💬 |
89 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | 1件: Somatotropin Somatotropin (Valtropin) | - | - | - | 1件: 193 193 💬 |
90 | Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus | - | - | - | - | 1件: 53 53 💬 |
91 | Inactivated Trivalent Influenza vaccine | - | - | - | - | 1件: 63 63 💬 |
92 | INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI | - | - | - | - | 1件: 294 294 💬 |
93 | Influenza vaccination | - | - | - | - | 1件: 299 299 💬 |
94 | Influenza vaccine | - | - | - | - | 5件: 11 11, 13, 46, 51, 84 💬 |
95 | INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) | - | - | - | - | 1件: 49 49 💬 |
96 | Influenza vaccine, Immune function | - | - | - | - | 1件: 107 107 💬 |
97 | Inhaled Vancomycin | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 299 299 💬 |
98 | Injection of autologous stromal vascular fraction | - | - | - | - | 1件: 51 51 💬 |
99 | IV vancomycin hydrochloride | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 299 299 💬 |
100 | Loestrin (norethindrone acetate and ethinyl estradiol) (Vagifem (TN)) | 4件: Acetate Acetate, Estradiol (Estradiol Vaginal Inserts), Ethinylestradiol, Norethisterone | 3件: Estradiol
Estradiol
(Vagifem (TN)),
Norethindrone
,
Ethinyl estradiol
💬 | 3件: ESR1 ESR1, ESR2, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 💬 |
101 | Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) (Vagifem (TN)) | 4件: Acetate Acetate, Estradiol (Estradiol Vaginal Inserts), Ethinylestradiol, Norethisterone | 3件: Estradiol
Estradiol
(Vagifem (TN)),
Norethindrone
,
Ethinyl estradiol
💬 | 3件: ESR1 ESR1, ESR2, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 46 46, 49 💬 |
102 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件: 107 107 💬 |
103 | Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | - | - | - | - | 1件: 13 13 💬 |
104 | Metronidazole (Vandazole (TN)) | 1件: Metronidazole Metronidazole (Metronidazole Vaginal) | 1件: Metronidazole
Metronidazole
(Vandazole (TN)) 💬 | - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬 |
105 | Metronidazole capsule 50 mg (Vandazole (TN)) | 1件: Metronidazole Metronidazole (Metronidazole Vaginal) | 1件: Metronidazole
Metronidazole
(Vandazole (TN)) 💬 | - | - | 1件: 97 97 💬 |
106 | Metronidazole Oral (Vandazole (TN)) | 1件: Metronidazole Metronidazole (Metronidazole Vaginal) | 1件: Metronidazole
Metronidazole
(Vandazole (TN)) 💬 | - | - | 1件: 96 96 💬 |
107 | Mirapexin extended release various strengths | 2件: Manganese citrate Manganese citrate, Pramipexole | 1件: Pramipexole
Pramipexole
💬 | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
108 | Moderna COVID-19 Vaccine | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
(COVID-19 mRNA vaccine (nucleotide modified)) 💬 | - | - | 1件: 46 46 💬 |
109 | Most recent vaccine to seasonal influenza | - | - | - | - | 1件: 13 13 💬 |
110 | MRNA COVD19 vaccine | - | - | - | - | 3件: 49 49, 53, 271 💬 |
111 | Multi-modal pain management [Valium + Gabapentin] | 1件: Gabapentin Gabapentin (Van-gabapentin) | 1件: Gabapentin
Gabapentin
💬 | 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 70 70 💬 |
112 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | 1件: Myelin basic protein Myelin basic protein | - | - | - | 1件: 13 13 💬 |
113 | Needle biopsy of the vastus lateralis muscle | - | - | - | - | 1件: 113 113 💬 |
114 | Oral Vancomycin | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 2件: 94 94, 296 💬 |
115 | Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg (Vagifem (TN)) | 3件: Estradiol Estradiol (Estradiol Vaginal Inserts), Ethinylestradiol, Norgestimate | 3件: Estradiol
Estradiol
(Vagifem (TN)),
Ethinyl estradiol
,
Norgestimate
💬 | 3件: ESR1 ESR1, ESR2, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 💬 |
116 | Other vasodilator | - | - | - | - | 1件: 51 51 💬 |
117 | PB1046, VIP-ELP1-120, Vasomera | - | - | - | - | 1件: 86 86 💬 |
118 | Pertussis vaccine | 1件: Pertussis vaccine Pertussis vaccine | 1件: Pertussis vaccine
Pertussis vaccine
💬 | - | - | 2件: 13 13, 46 💬 |
119 | Pneumococcal conjugate vaccine | - | - | - | - | 1件: 46 46 💬 |
120 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | 2件: 13 13, 14 💬 |
121 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | 4件: Aluminium Aluminium, Aluminium phosphate, Corynebacterium diphtheriae CRM197 protein (Vaxneuvance), Phosphate ion | - | - | - | 1件: 46 46 💬 |
122 | Pneumococcal polysaccharide vaccine | - | - | - | - | 3件: 13 13, 46, 222 💬 |
123 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) | - | - | - | - | 1件: 46 46 💬 |
124 | Pneumococcal polysaccharide vaccine 23 valent | - | - | - | - | 1件: 265 265 💬 |
125 | Pneumococcal polysaccharide vaccine solution for injection in a vial | - | - | - | - | 1件: 222 222 💬 |
126 | Pneumovax® (pneumococcal polysaccharide vaccine) | - | - | - | - | 1件: 65 65 💬 |
127 | Polidocanol (Varithena (TN)) | 1件: Polidocanol Polidocanol (Varithena) | 1件: Polidocanol
Polidocanol
(Varithena (TN)) 💬 | - | - | 1件: 279 279 💬 |
128 | Prevenar vaccination | - | - | - | - | 1件: 46 46 💬 |
129 | Prevenar vaccine | - | - | - | - | 1件: 46 46 💬 |
130 | Prevenar® (7-valent pneumococcal conjugate vaccine) | - | - | - | - | 1件: 65 65 💬 |
131 | Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal) | - | - | - | - | 1件: 13 13 💬 |
132 | Purified Vero Cell Vaccine) | - | - | - | - | 1件: 65 65 💬 |
133 | Quadrivalent HPV vaccine | - | - | - | - | 1件: 107 107 💬 |
134 | Quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 💬 |
135 | Recombinant zoster vaccine | - | - | - | - | 2件: 13 13, 49 💬 |
136 | Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬 |
137 | RNL-Vascostem® | - | - | - | - | 1件: 47 47 💬 |
138 | RT234 - vardenafil inhalation powder | 1件: Vardenafil Vardenafil | 1件: Vardenafil
Vardenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
139 | SACUBITRIL VALSARTAN | 2件: Sacubitril Sacubitril, Valsartan | 2件: Valsartan
Valsartan
,
Sacubitril
💬 | 2件: AGTR1 AGTR1, MME 💬 | 19件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬 |
140 | Sacubitril/Valsartan | 2件: Sacubitril Sacubitril, Valsartan | 2件: Valsartan
Valsartan
,
Sacubitril
💬 | 2件: AGTR1 AGTR1, MME 💬 | 19件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬 |
141 | SARS-COV-2 mRNA Vaccine | 2件: CVnCoV CVnCoV (SARS-CoV-2 mRNA vaccine), SARS-CoV-2 mRNA vaccine | - | - | - | 1件: 13 13 💬 |
142 | Seasonal influenza vaccine | - | - | - | - | 2件: 13 13, 46 💬 |
143 | Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | - | - | - | - | 1件: 84 84 💬 |
144 | Seasonal Quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 💬 |
145 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | 1件: 96 96 💬 |
146 | Sodio valproato | - | - | - | - | 1件: 144 144 💬 |
147 | Sodium Valproate | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 4件: 2 2, 90, 102, 256 💬 |
148 | Sodium valproate 200 mg gastro-resistant tablets | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 233 233 💬 |
149 | Sodium Valproate 200Mg E/C Tablet | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 233 233 💬 |
150 | Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 233 233 💬 |
151 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | 5件: Arginine Arginine (Vamin N), Clonidine, Estradiol (Estradiol Vaginal Inserts), Estradiol valerate, Somatotropin (Valtropin) | 4件: Estradiol
Estradiol
(Vagifem (TN)),
Clonidine
,
Estradiol valerate
,
Arginine
💬 | 5件: ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬 |
152 | Stromal Vascular fraction | - | - | - | - | 1件: 51 51 💬 |
153 | Stromal vascular fraction (SVF) | - | - | - | - | 1件: 96 96 💬 |
154 | T cell vaccination | - | - | - | - | 1件: 13 13 💬 |
155 | T-Cell Vaccination | - | - | - | - | 1件: 13 13 💬 |
156 | Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication) (Vandazole (TN)) | 3件: Amoxicillin Amoxicillin, Clarithromycin, Metronidazole (Metronidazole Vaginal) | 4件: Amoxicillin
Amoxicillin
,
Clarithromycin
,
Metronidazole
(Vandazole (TN)),
Amoxicillin
💬 | - | - | 1件: 63 63 💬 |
157 | TBE-vaccine | - | - | - | - | 1件: 46 46 💬 |
158 | Tetanus + pnemococcal vaccines alone | - | - | - | - | 1件: 46 46 💬 |
159 | Tetanus diphtheria toxoid vaccine (Td) | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 1件: 13 13 💬 |
160 | Tetanus diphtheria toxoids vaccine | - | - | - | - | 1件: 13 13 💬 |
161 | Tetanus toxoid (TT) containing vaccine (Td, Tdap) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 1件: 13 13 💬 |
162 | Tetanus toxoid adsorbed booster vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 1件: 46 46 💬 |
163 | Tetanus Toxoid Adsorbed Vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 1件: 46 46 💬 |
164 | Tetanus toxoid vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis) | - | - | - | 1件: 13 13 💬 |
165 | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) | 3件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) (Vaxelis), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Vaxelis), Pertussis vaccine | 1件: Pertussis vaccine
Pertussis vaccine
💬 | - | - | 1件: 46 46 💬 |
166 | Tetanus vaccin | - | - | - | - | 1件: 11 11 💬 |
167 | Tetanus, diphtheria, and acellular pertussis vaccine | 1件: Pertussis vaccine Pertussis vaccine | 1件: Pertussis vaccine
Pertussis vaccine
💬 | - | - | 1件: 13 13 💬 |
168 | The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide | - | - | - | - | 1件: 222 222 💬 |
169 | Tovaxin Autologous T Cell Vaccine | - | - | - | - | 1件: 13 13 💬 |
170 | Tozinameran (COVID-19 mRNA vaccine (nucleoside-modified)) | 1件: Tozinameran Tozinameran (Pfizer-BioNTech Covid-19 Vaccine) | 1件: Tozinameran
Tozinameran
(COVID-19 mRNA vaccine (nucleoside-modified)) 💬 | - | - | 1件: 299 299 💬 |
171 | Trivalent inactivated influenza vaccine | - | - | - | - | 1件: 46 46 💬 |
172 | Trivalent seasonal influenza vaccine | - | - | - | - | 1件: 13 13 💬 |
173 | TT Vaccine | - | - | - | - | 1件: 13 13 💬 |
174 | VA | - | - | - | - | 2件: 90 90, 302 💬 |
175 | Vaccin grippal pandémique H1N1 | - | - | - | - | 1件: 299 299 💬 |
176 | Vaccination | - | - | - | - | 1件: 49 49 💬 |
177 | Vaccination against TBE | - | - | - | - | 1件: 46 46 💬 |
178 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 💬 |
179 | Vaccine | - | - | - | - | 1件: 49 49 💬 |
180 | Vaccine Vivotif + Vaccine Dukoral | 6件: Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live, Vibrio cholerae Inaba 48 classical biotype, heat inactivated, Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, heat inactivated | - | - | - | 1件: 97 97 💬 |
181 | Vaccine Vivotif + Vaccine Dukoral + oats | 7件: Oat Oat, Recombinant Cholera Toxin B Subunit, Typhoid Vaccine Live, Vibrio cholerae Inaba 48 classical biotype, heat inactivated, Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated, Vibrio cholerae Ogawa 50 classical biotype, heat inactivated | - | - | - | 1件: 97 97 💬 |
182 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | 3件: 61 61, 62, 66 💬 |
183 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | 2件: 61 61, 62 💬 |
184 | VACCINO PNEUMOCOCCICO | - | - | - | - | 2件: 62 62, 66 💬 |
185 | VACCINO PNEUMOCOCCICO SACCARIDICO | - | - | - | - | 1件: 14 14 💬 |
186 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | 3件: 61 61, 62, 66 💬 |
187 | VAD044 | - | - | - | - | 1件: 227 227 💬 |
188 | Vaginal estriol | 1件: Estriol Estriol | 2件: Estriol
Estriol
,
Estriol tripropionate
💬 | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬 |
189 | VAL-1221 | - | - | - | - | 1件: 256 256 💬 |
190 | Valacyclovir | 1件: Valaciclovir Valaciclovir | 2件: Valaciclovir
Valaciclovir
,
Valaciclovir hydrochloride hydrate
💬 | - | - | 1件: 65 65 💬 |
191 | Valbenazine | 1件: Valbenazine Valbenazine | 1件: Valbenazine
Valbenazine
💬 | 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 💬 |
192 | Valdecoxib | 1件: Valdecoxib Valdecoxib | 1件: Valdecoxib
Valdecoxib
💬 | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬 |
193 | Valerian | 1件: Valerian Valerian | - | - | - | 1件: 6 6 💬 |
194 | Valganciclovir | 1件: Valganciclovir Valganciclovir | 1件: Valganciclovir
Valganciclovir
💬 | - | - | 4件: 85 85, 97, 299, 331 💬 |
195 | Valganciclovir (VGC) | 1件: Valganciclovir Valganciclovir | 1件: Valganciclovir
Valganciclovir
💬 | - | - | 1件: 331 331 💬 |
196 | Valganciclovir [Valcyte] | 1件: Valganciclovir Valganciclovir | 1件: Valganciclovir
Valganciclovir
💬 | - | - | 1件: 299 299 💬 |
197 | Valiloxybate | 1件: Valiloxybate Valiloxybate | 1件: Valiloxybate
Valiloxybate
💬 | 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
198 | Valproate | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 6件: 2 2, 3, 90, 102, 233, 256 💬 |
199 | VALPROATE SODIUM | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 💬 |
200 | Valproate, Levocarnitine | 2件: Levocarnitine Levocarnitine, Valproic acid | 2件: Valproic acid
Valproic acid
,
Levocarnitine
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 💬 |
201 | Valproic Acid | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 7件: 3 3, 5, 26, 65, 90, 222, 256 💬 |
202 | Valproic Acid (VPA) | 1件: Valproic acid Valproic acid | 1件: Valproic acid
Valproic acid
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 💬 |
203 | Valproic Acid and Levocarnitine | 2件: Levocarnitine Levocarnitine, Valproic acid | 2件: Valproic acid
Valproic acid
,
Levocarnitine
💬 | 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 3 3 💬 |
204 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 💬 |
205 | Valsartan | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 57 57, 58, 66, 75, 218, 222, 224 💬 |
206 | Vamarolone | - | - | - | - | 1件: 113 113 💬 |
207 | Vaminolac | - | - | - | - | 1件: 97 97 💬 |
208 | Vaminolac, komb. | - | - | - | - | 1件: 97 97 💬 |
209 | Vamorolone | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 113 💬 |
210 | Vamorolone 0.25 mg/day/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
211 | Vamorolone 0.25 mg/kg/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
212 | Vamorolone 0.75 mg/day/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
213 | Vamorolone 0.75 mg/kg/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
214 | Vamorolone 2.0 mg/day/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
215 | Vamorolone 2.0 mg/kg/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
216 | Vamorolone 4% suspension for oral dosing | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
217 | Vamorolone 6.0 mg/day/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
218 | Vamorolone 6.0 mg/kg/day | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬 |
219 | Vancomycin | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 💬 |
220 | Vancomycin hydrochloride inhalation powder | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 299 299 💬 |
221 | Vancomycin inhalation powder | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 299 299 💬 |
222 | Vancomycin Oral Capsule | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 97 97 💬 |
223 | Vancomycin Pre-Treat | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 97 97 💬 |
224 | Vancomycin Pre-Treatment | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 97 97 💬 |
225 | Vantobra (tobramycin) | 1件: Tobramycin Tobramycin (Vantobra) | 1件: Tobramycin
Tobramycin
💬 | - | - | 1件: 299 299 💬 |
226 | Vardenafil | 1件: Vardenafil Vardenafil | 1件: Vardenafil
Vardenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 86, 299 💬 |
227 | Vardenafil (hidrocloride) | 1件: Vardenafil Vardenafil | 1件: Vardenafil
Vardenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬 |
228 | Vardenafilo | 1件: Vardenafil Vardenafil | 1件: Vardenafil
Vardenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬 |
229 | VARDENAFILO HIDROCLORURO | 1件: Vardenafil Vardenafil | 1件: Vardenafil
Vardenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬 |
230 | VARENICLINE | 1件: Varenicline Varenicline | 1件: Varenicline
Varenicline
💬 | 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 3件: 6 6, 18, 53 💬 |
231 | Varenicline Nasal Spray | 1件: Varenicline Varenicline | 1件: Varenicline
Varenicline
💬 | 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 1件: 53 53 💬 |
232 | VARENICLINE TARTRATE | 1件: Varenicline Varenicline | 1件: Varenicline
Varenicline
💬 | 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 1件: 6 6 💬 |
233 | VARI | - | - | - | - | 2件: 62 62, 274 💬 |
234 | Variation of behaviors of Parkinson's disease | - | - | - | - | 1件: 6 6 💬 |
235 | Varicella Zoster Vaccine | - | - | - | - | 1件: 46 46 💬 |
236 | Various | - | - | - | - | 1件: 95 95 💬 |
237 | Vaseline | - | - | - | - | 1件: 51 51 💬 |
238 | Vasoactive intestinal peptide | - | - | - | - | 1件: 85 85 💬 |
239 | Vasomera (PB1046) Injection | - | - | - | - | 1件: 86 86 💬 |
240 | Vasopressin | 1件: Vasopressin Vasopressin | 1件: Vasopressin
Vasopressin
💬 | 3件: AVPR1A AVPR1A, AVPR1B, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 210 210 💬 |
241 | Vasopressin, Arginine | 2件: Arginine Arginine (Vamin N), Vasopressin | 2件: Vasopressin
Vasopressin
,
Arginine
💬 | 3件: AVPR1A AVPR1A, AVPR1B, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 210 210 💬 |
242 | Vastarel | - | - | - | - | 2件: 2 2, 58 💬 |
243 | Vastarel 20mg film coated tablets | - | - | - | - | 1件: 58 58 💬 |
244 | Vatelizumab | 1件: Vatelizumab Vatelizumab | - | - | - | 2件: 13 13, 97 💬 |
245 | VATIQUINONE | 1件: Vatiquinone Vatiquinone | 1件: Vatiquinone
Vatiquinone
💬 | - | - | 2件: 18 18, 21 💬 |
246 | Vaxzevria | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 💬 |
247 | Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 💬 |
248 | VAY736 | - | - | - | - | 9件: 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬 |
249 | VAY736 antibody | - | - | - | - | 1件: 53 53 💬 |
250 | VAY736 higher dose | - | - | - | - | 1件: 53 53 💬 |
251 | VAY736 lower dose | - | - | - | - | 1件: 53 53 💬 |
252 | With U-VANCO (vancomycin hydrochloride) | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 70 70 💬 |
253 | Without U-VANCO (vancomycin hydrochloride) | 1件: Vancomycin Vancomycin | 1件: Vancomycin
Vancomycin
💬 | - | - | 1件: 70 70 💬 |
254 | Yellow fever vaccine | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: Yellow fever vaccine
Yellow fever vaccine
💬 | - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 💬 |
255 | Yellow Fever vaccine (17D) | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: Yellow fever vaccine
Yellow fever vaccine
💬 | - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 💬 |
256 | Zostavax (varicella zoster virus) vaccine | 1件: Varicella zoster vaccine (live/attenuated) Varicella zoster vaccine (live/attenuated) | - | - | - | 1件: 46 46 💬 |
257 | Zostavax vaccine | 1件: Varicella zoster vaccine (live/attenuated) Varicella zoster vaccine (live/attenuated) | - | - | - | 2件: 46 46, 49 💬 |